Clinical Trial

Safety and Tolerability Evaluation of Akkermansia Muciniphila

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 29, 2025 (before its estimated December 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of Akkermansia muciniphila Akk11 in healthy adult.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-05.
Trial Details
NCT Number NCT06728098
Lead Sponsor Wecare Probiotics Co., Ltd.
Conditions Healthy
Enrollment 108 participants
Start Date 2025-11-25
Primary Completion 2025-12-25 (estimated)
Study Completion 2026-03-25 (estimated)
Updated on ClinicalTrials.gov 2025-07-29